Works in Journal of Gynecologic Oncology, 2024, Vol 35, Issue 6
Results: 21
Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e118
- Publication type:
- Article
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e117
- By:
- Publication type:
- Article
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e113
- By:
- Publication type:
- Article
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e106
- By:
- Publication type:
- Article
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e105
- By:
- Publication type:
- Article
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e103
- By:
- Publication type:
- Article
Genetic analysis of cervical cancer with lymph node metastasis.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e102
- By:
- Publication type:
- Article
The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e101
- By:
- Publication type:
- Article
Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e100
- By:
- Publication type:
- Article
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e86
- By:
- Publication type:
- Article
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e85
- By:
- Publication type:
- Article
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e84
- By:
- Publication type:
- Article
The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e80
- By:
- Publication type:
- Article
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e79
- By:
- Publication type:
- Article
Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e78
- By:
- Publication type:
- Article
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e77
- By:
- Publication type:
- Article
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e76
- By:
- Publication type:
- Article
Influence of cancer in pregnancy on obstetric and neonatal outcomes: an observational retrospective cohort study.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e74
- By:
- Publication type:
- Article
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e73
- By:
- Publication type:
- Article
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e72
- By:
- Publication type:
- Article
Mirvetuximab soravtansine in platinum-resistant recurrent ovarian cancer with high folate receptor-alpha expression: a cost-effectiveness analysis.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e71
- By:
- Publication type:
- Article